Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. Genzyme Corporation
Case Number:
8:10-cv-00549
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 12, 2014
NJ, Fla. To Get Slices Of $22M Genzyme FCA Settlement
The state of New Jersey has joined a $22 million settlement to resolve former Genzyme Corp. employees' False Claims Act allegations in Florida federal court that the company marketed its Seprafilm adhesion barrier for unapproved uses, Acting Attorney General John J. Hoffman said Wednesday.
-
May 03, 2012
Genzyme Irons Out FCA Suits Over Surgery Product Marketing
A Florida federal judge on Thursday tossed two whistleblower False Claims Act suits brought by former Genzyme Corp. employees and a doctor accusing the company of improperly marketing its Seprafilm adhesion barrier, after the federal government said the parties had reached a proposed settlement.